chrisvoncsefalvay/vaers-outcomes huggingface dataset:
His blood pressure keeps going up right now it is like 191/111, which is really high; Has been experiencing like severe headache for the past two days; This is a spontaneous report from a contactable consumer.  A 54-years-old male patient (reporter boyfriend, anesthesiologist) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Dec2020 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced severe headache for the past two days and his blood pressure keeps going up on Dec2020 with outcome of not recovered.  On unspecified date the blood pressure was like 191/111, which was really high. As treatment the patient took some type of analgesic, ibuprofen (MOTRIN) or something, and he also took Propranolol to try to get his blood pressure down but it kept going up. The patient underwent COVID test on unspecified date with unknown results.   Information on lot/batch number are requested.
Patient had nausea and vomiting after receiving pneumococcal vaccine.  Patient arm was swollen, tender to touch, and patient had difficulty bending his arm.
Patient admitted to the hospital the day after receiving a COVID vaccine x 5 days. Patient passed away on 2/23/2021.
Employee states high fever and body aches approximately 10 hours after vaccine. Symptoms lasted approximately 1 day.
All injection symptoms went away after a few days.  Then a week after the first vaccine injection(Wed) I woke up and the injection site was extremely itchy.  I looked at it and it was red, swollen and very hot to the touch and painful to the touch.  At the top of the red area it looked like there were hives.  I felt a bit tired and a little bit achy.  Based on what I had seen online I iced the area and that helped.  The next day(thurs) I woke u and the injection site was less itchy, less red and less swollen but I was more achy and more tired.  I needed a nap.  I continued to ice the injection site.  The following day (Fri) I woke up and the injection site was less swollen, less red and almost not itchy at all.  I was less achy but still very tired and needed another nap during the day.
patient received 1 Moderna COVID-19 vaccine in 2021 and for the 2nd dose they received Pfizer; patient received 1 Moderna COVID-19 vaccine in 2021 and for the 2nd dose they received Pfizer; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (patient received 1 Moderna COVID-19 vaccine in 2021 and for the 2nd dose they received Pfizer), COVID-19 IMMUNISATION (patient received 1 Moderna COVID-19 vaccine in 2021 and for the 2nd dose they received Pfizer) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (patient received 1 Moderna COVID-19 vaccine in 2021 and for the 2nd dose they received Pfizer), COVID-19 IMMUNISATION (patient received 1 Moderna COVID-19 vaccine in 2021 and for the 2nd dose they received Pfizer) and NO ADVERSE EVENT (No adverse event). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (patient received 1 Moderna COVID-19 vaccine in 2021 and for the 2nd dose they received Pfizer), COVID-19 IMMUNISATION (patient received 1 Moderna COVID-19 vaccine in 2021 and for the 2nd dose they received Pfizer) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INTERCHANGE OF VACCINE PRODUCTS (patient received 1 Moderna COVID-19 vaccine in 2021 and for the 2nd dose they received Pfizer) and COVID-19 IMMUNISATION (patient received 1 Moderna COVID-19 vaccine in 2021 and for the 2nd dose they received Pfizer).    Concomitant products were not reported.  It was reported that patient received first dose from moderna and the second dose from Pfizer vaccine.   Treatment medications were not reported.   Reporter did not allow further contact
fever of 103 w/6 to 8 cm area of cellulitis & edema @ site;
Conditions developing after vaccine:  extreme exacerbation of all symptoms prior to vaccine. including pain, esp abdominal pain, nauaea, joint/muscle pain, extreme fatigue that is way more then normal, and respitory infections. Altering of pattern of symptoms with the F.M.Fever.  AND NOW APS AND A DYING OR DEAD SPLEEN- (Blood clotting issue)  First vaccination for covid was 6-7-21 and 6-28-21. This was the first set that was produced by Pfizer given at clinic. Age was 62.  After this vaccine I also suffered from the increase in all of my symptoms and the alteration in my pattern of symptoms from FMF. Sadly I did not make the connection untilm after the sec. vaccine for covid 19 in 2022.  Second vaccine was the covid-19 vaccine and it was on Oct. 24th in 2022, This was at another clinic- Age was 64.  First week after vaccine was received, extremely fatigued all over, could hardly move.  Hospital stay was in Nov. of 2022 from exacerbation of symptoms from existing illness. Approx. a 5-6 day stay.  Nov. of 2022, did not sign discharge papers sonce I was kicked out of hosp by Dr. on Nov, 28 th with no reason given.  Dr. did some testing on me trying to see if I may have developed Amyloidosis due to the spleen issue, this is when she discovered the APS (antiphospholipid syndrome) issue and agreed it could be from the vaccine since after the vaccine I experience many symptoms and this had already been reported as after vaccine issues. The test was a set of 3 tests, first one being for the beta 2 glycoprotein ,and mine came back reading 65, and it should be below 20.  The tests include lupus anticoagulant (LA), anticardiolipin (aCL) antibodies (immunoglobulin G [IgG] and IgM), and anti-beta-2 glycoprotein 1 (anti-B2GP1) antibodies (IgG and/or IgM).  I was neg. on the other 2 teats and will retest in June for the Beta 2 test.  *****The Patient has not recovered from reaction to the covid vaccine and covid -19 vaccines. This reaction is life threatening and causing permanent damage to spleen.  At the 2022 vaccine I was also given the flu vaccine for that year, 2022, and have never had any issues from previous flu vaccines which I have gotten almost all of them.  Information on Vaccine lot numbers etc. can be obtained by calling clinic for the info.  I also need you to reach out to my Dr. for her report on this issue as well.
LIGHT HEADEDNESS (HER HEAD DOES NOT FEEL CONNECTED TO HER BODY); LIGHT SENSITIVITY; FLU-LIKE SYMPTOMS; CHILLS; HEADACHE; NAUSEA; TIREDNESS; This spontaneous report received from a patient concerned a 61 year old female. The patient's weight was 106 pounds, and height was not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A-21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced flu-like symptoms. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced headache. On 10-APR-2021, the subject experienced nausea. On 10-APR-2021, the subject experienced tiredness. On 11-APR-2021, the subject experienced light sensitivity. On 12-APR-2021, the subject experienced light headedness (her head does not feel connected to her body). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu-like symptoms, chills, headache, and nausea on 11-APR-2021, and light sensitivity on 13-APR-2021, and was recovering from tiredness, and light headedness (her head does not feel connected to her body). This report was non-serious.
This spontaneous report as received from Registered Nurse regarding multiple unspecified number of patients of unknown age and gender. The medical history of patients and their concurrent conditions were not reported. On unspecified dates, multiple unspecified number of patients were vaccinated with improperly stored doses of RECOMBIVAX HB (therapy type unknown) (lot # L044917, expiry date 05-OCT-2018) dosage regimen and route unknown. Concomitant medications were not reported. No adverse effects were reported. Product quality complaint (PQC) was not filed. This report is one of the several reports received from the same reporter. Additional information has been requested.
dizziness; low grade fever; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced dizziness and low grade fever on an unspecified date that lasted for 3 days. People she talked with said they have gotten reactions after 2nd dose of vaccine but not first. She was wondering if she should get 2nd of Covid vaccine. She was also scheduled for yearly blood work tomorrow, and was wondering if she should reschedule blood work. The outcome of the events was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
PROQUAD was administered after a temperature excursion to patient. Date of administration is Sep 1, 2023. No further information provided. No additional AE reported; PROQUAD was administered after a temperature excursion to patient. Date of administration is Sep 1, 2023. No further information provided. No additional AE reported; This spontaneous report was received from a licensed practical nurse referring to a 5-year-old patient of unknown age and gender. The patient's current conditions, medical history or concomitant therapies were not reported.  On 01-SEP-2023, the patient was vaccinated with a dose of measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) as prophylaxis, lot# X013909, expiry date: 10-NOV-2024, recombinant Human albumin (rHA) (dose, and route of administration were not provided) after a temperature excursion (TE) (product storage error) of 6°F for 20 minutes. There was no previous temperature excursion. No additional adverse event reported.
to ED c/o SOB, weakness, fever, cough, diarrhea; + COVID pneumonia and sepsis, TX: zithromax, merrem, remdesevir, Vit C, Zinc, Singulair, Solu-medrol, lovenox, O2 15 lpm, abx stopped d/t procalcitonin less than 0.25.; upon discharge home, O2 decrease 2 lpm
Heart palpitations,  Pulse 99, BP 218/116.  Was referred to a cardiologist.
Age: 70 y.o.  Admit Date: 7/20/2022 10:06 PM Discharge Date:  7/23/2022  Admitting Physician:  Discharge Physician: Medical Doctor   Discharge Diagnosis: Principal Problem:   NSTEMI (non-ST elevated myocardial infarction) Active Problems:   COVID-19   PAF (paroxysmal atrial fibrillation)       HPI: Patient "is a 70 y.o. female with a history of ablation 2 days ago for atrial fibrillation and also with complaints of intermittent palpitations since the procedure. Associated chest pain. Not sure what makes symptoms better or worse. Denies any shortness of breath, abdominal pain, nausea, vomiting, fever or any other concerning symptoms. Tested positive for covid.  Labs revealed troponin 0.5. admitted for further evaluation."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * NSTEMI (non-ST elevated myocardial infarction) o NSTEMI. Appears to be type 2 due to A fib RVR. No chest pain. Trop peaked at 0.51, cardiology following. No ischemic workup planned. o PAF with RVR: continued to have palpitations s/p ablation. Continued Amiodarone drip. She went back in sinus rhythm. Transition to by mouth amiodarone per cardiology/cleared for discharge for follow-up of patient.   o Covid 19: new.  Supplements.  Repeat with rapid test is negative. Follow-up outpatient. Continue supplements as ordered. Ambulatory care manager referral given.          Physical Exam on the Date of Discharge: Stable and improved       Consults:   IP CONSULT TO CARDIOLOGY IP CONSULT TO SOCIAL WORK   Significant Diagnostic Studies:    labs, radiology, and cardiac graphics: per chart.     Disposition:  home   Discharge Condition:  good
Pain in left arm; Fatigue; Temp 99.8; This is a spontaneous report from a contactable consumer, the patient. A 12-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 24May2021 at 16:30 (at the age of 12-years-old), as a dose 1, single for COVID-19 immunisation. The patient medical history included attention deficit hyperactivity disorder (ADHD), anxiety and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any allergies to medications, food or other products The patient did not receive any other vaccines within four weeks prior to the vaccination.The Concomitant medications included guanfacine hydrochloride (INTUNIV) 2 mg from an unknown date for unspecified indication. The Patient was experienced pain in left arm, fatigue and temperature 99.8 on 25May2021 at 07:00, Therapeutic measures were taken and included treatment with ibuprofen. The outcome of events pain in left arm, fatigue, and temp 99.8 was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Day 2, 3: Mild flu like symptoms Day 6: mild tingling sensation observed in toes and feet Day 7-Day 14: progressively worse tingling and burning sensation in feet, progressed up legs, arms, hands.  Day 8: ER called it parathesia Dose 2: noticed the burning within 3 hrs much more intense in my feet and legs, now at 6 hrs post 2nd vaccine (04.May.2021) progression of burning and tingling feet, legs, arms, hands, some torso, mild pain when take deep breath.  First reaction resolved after 2 1/2 weeks. In full blown day 1 of 2nd dose reaction.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Amoxicillin, reaction(s): "Known allergies: amoxicillin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: tested negative after taking Paxlovid; Positive, notes: tested positive for Covid about a week after last dose of Paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
BODY BURNING; CHILLS; FEVER; HEADACHE; FEELING EXTREMELY WEAK; This spontaneous report received from a patient concerned a 56 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included COPD and former smoker, and other pre-existing medical conditions included no known drug allergies, drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced body burning. On 02-APR-2021, the subject experienced chills. On 02-APR-2021, the subject experienced fever. On 02-APR-2021, the subject experienced headache. On 02-APR-2021, the subject experienced feeling extremely weak. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103 F. Treatment medications (dates unspecified) included: prednisone, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, chills, body burning, headache and feeling extremely weak. This report was non-serious.
Patient should have received a monovalent Covid vaccination as it was her first in the series, I overlooked this and administered the bivalent Covid booster. No adverse affects were reported.
Patient had arm soreness that extended from the upper arm and shoulder area, she had pain and some limitation with movement.  She said it was improving some over the last 5 days but was still sore and stiff.  The symptoms started about 24 hours after the shot
tongue may have started swelling soon after injection but was causing no concern. while sleeping, swelling increased to cause issues with breathing and swallowing as well as swelling to throat and face. Woke early and noticed swelling and went to urgent care. Was given benadryl and decadron shot to help with symptoms. Was released 1 hour later.
Patient had  syncope episode immediately after MENACTRA vaccine + HGB blood draw. Pt was sitting on exam table and stated. I didn't feel good, I don't like the sight of blood" and then fell to side lying position on table immune X 2-35 seconds. Recovered /drank juice / stable vs & left office in stable condition.
Cough, fever of 101.8, lethargy, cough syrup and Motrin.
Information has been received from a registered nurse referring to an unspecified number of unspecified patients of unknown age and gender. The patients' pertinent medical history and drug reactions/allergies were not reported. On unspecified dates, the patients were vaccinated with an unspecified number of doses of RECOMBIVAX HB, intramuscularly (lot# was not reported) which were each greater than the prescribed 0.5 ml. The nurse reported this occurred due to the fact that healthcare providers at her facility withdrew administered the entire contents of single-dose vials of all vaccines, and due to expected slight overfill of RECOMBIVAX HB single-dose vials. The doses that were ultimately administered to the patients could therefore range anywhere from 0.55 ml to 0.6 ml. No adverse effects were reported. No product quality complaint was identified since slight overfill of single-dose vials was expected. This is one of several cases from the same reporter. Additional information has been requested.
Arm pain, redness, swelling reached 5" below injection site and around arm even with site. Loss of appetite, fever, chills, headache, all lasted 2 days, started to see improvement on 3rd day. Took extra strength Tylenol.
Headache, body aches, sore skin, muscles, joints, dizziness, breathlessness, nausea, loss of appetite, tips of fingers hypersensitive sending pain through my fingers and hands, similar sharp shooting pain in toes and feet - nothing like I have ever felt before. All subsided after one week except for the pain in my hands, arms, feet, and legs - weird, unusual pain unlike anything I?ve experienced before.
About 45 minutes after I got vaccinated I started to feel a strange sensation (a kind of tingling) in the right side of my head, inner ear,  and jaw. Then about 15 minutes later I felt the sensation in the right side of my tongue. The best way I can describe it is similar to the same sensations I feel when the Novakane is wearing off after having a cavity filled. It's Monday (4/12/21) and I can still feel it a tiny bit in my right ear, where my jaw connects (right side), and my right cheek. Hopefully, it will go away when the stiffness in my shoulder goes away.  Also, during my 15 minute waiting period I had the same tingly sensation going down my arm to my fingertips, but I was told that some people experience that sensation as the vaccine moves throughout their body. Other than that I experienced the stated side effects.
Low grade fever, pain at injection site, extreme body aches, diarrhea, stomach cramps/pain, fatigue, and no appetite. These lasted for about 36hrs.
Pt noticed rash/itching to deltoid area, site of vaccination starting 2 hours ago, day 5 after receiving the booster. This is her Pfizer Covid 19 booster dose 6 months after her regular series. No signs of anaphylaxis. No difficulty breathing. No hives. Rash is localized to the deltoid region. She applied hydrocortisone cream and took a benadryl. Minimal relief. She has epipen on hand as she is allergic to wasps and aspartame.
Redness, swelling with knots in arm pit, breast, and groin. Started morning after injection. Treated with warm moist compresses Tylenol every 4 hours.
Case number PHEH2044US003692, is an initial spontaneous report from a pharmacist received on 21 FEB 2014. This report refers to a 12-year-old male patient. The patient's medical history and concomitant medications were not reported. This patient under the age of 18 years was vaccinated with 0.5 ml of FLUCELVAX (batch number: unknown) intramuscularly on 02 DEC 2013. No adverse event was reported following the medication error.  Following an internal review on 18 AUG 2013 of the data received on 21 FEB 2014, it was identified that the BPI labeling of the event, "inappropriate age at vaccine administration" was erroneously captured as listed and hence the labeling was now changed as unlisted and second indication off'-label use was added to the case".
Seizure that evening associated with temperature of 102 degrees, axillary. Duration of seizure estimated at 20-30 minutes per father.
A non-serious, spontaneous report of administration of expired FLUMIST to a 65 year old was received from a nurse practitioner concerning a 65-year-old male subsequent to FLUMIST. On 19-Jan-2009 the patient received FLUMIST that expired on 13-Jan-2009. There was no adverse event associated with this medication error; therefore treatment and reporter/sponsor causality assessments are not applicable and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from the previous season and 2) product expiring during the peak of the flu season resulting in some medication errors that occurred shortly after the product expired. Additional information was received on 05-Mar-2009 and incorporated into the narrative: confirmed no adverse events were reported following vaccination. Additional information received on 31-Mar-2009 included Product Complaint Investigation results.